Trial record 1 of 1 for:    mm-398 ferumoxytol
Previous Study | Return to List | Next Study

Pilot Study to Determine Biodistribution of MM-398 and Feasibility of Ferumoxytol as a Tumor Imaging Agent

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2013 by Merrimack Pharmaceuticals
Sponsor:
Information provided by (Responsible Party):
Merrimack Pharmaceuticals
ClinicalTrials.gov Identifier:
NCT01770353
First received: December 19, 2012
Last updated: August 8, 2013
Last verified: August 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2013
  Estimated Primary Completion Date: November 2013 (Final data collection date for primary outcome measure)